See All Slides - tctmd.com

Slides

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Presentation PCI Outcomes 2012

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Presenter: Manesh R. Patel

March 23, 2012

Presentation PCI Outcomes 2012

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Presenter: Antonio Colombo

March 23, 2012

Presentation PCI Outcomes 2012

Case 1: Multivessel PCI: Justification and Outcomes

Presenter: Frederick Feit

March 23, 2012

Presentation PCI Outcomes 2012

Optimizing Pharmacology Before, During and After PCI

Presenter: E. Magnus Ohman

March 23, 2012

Presentation PCI Outcomes 2012

PCI of Bifurcations and Trifurcations

Presenter: Yves Louvard

March 23, 2012

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

Presentation PCI Outcomes 2012

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Presenter: Gregg W. Stone

March 23, 2012

Presentation PCI Outcomes 2012

Imaging Guidance with IVUS

Presenter: Gary S. Mintz

March 23, 2012

Presentation PCI Outcomes 2012

Case 2: Integrated Use of IVUS and FFR

Presenter: Seung-Jung Park

March 23, 2012

Advertisement

Slides

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Case 1: Multivessel PCI: Justification and Outcomes

Optimizing Pharmacology Before, During and After PCI

PCI of Bifurcations and Trifurcations

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Imaging Guidance with IVUS

Case 2: Integrated Use of IVUS and FFR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content